Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10936 | 2021 |
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ... Nature medicine 10 (9), 942-949, 2004 | 6352 | 2004 |
Understanding the tumor immune microenvironment (TIME) for effective therapy M Binnewies, EW Roberts, K Kersten, V Chan, DF Fearon, M Merad, ... Nature medicine 24 (5), 541-550, 2018 | 4403 | 2018 |
Regulatory T cells, tumour immunity and immunotherapy W Zou Nature Reviews Immunology 6 (4), 295-307, 2006 | 2664 | 2006 |
Immunosuppressive networks in the tumour environment and their therapeutic relevance W Zou Nature reviews cancer 5 (4), 263-274, 2005 | 2626 | 2005 |
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations W Zou, JD Wolchok, L Chen Science translational medicine 8 (328), 328rv4-328rv4, 2016 | 2321 | 2016 |
Inhibitory B7-family molecules in the tumour microenvironment W Zou, L Chen Nature Reviews Immunology 8 (6), 467-477, 2008 | 2034 | 2008 |
CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy et al. Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P ... Nature 569 (7755), 270-274, 2019 | 1963 | 2019 |
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy N Nagarsheth, MS Wicha, W Zou Nature Reviews Immunology 17 (9), 559-572, 2017 | 1863 | 2017 |
Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy TC Yu, F Guo, Y Yu, T Sun, D Ma, J Han, Y Qian, I Kryczek, D Sun, ... Cell 170 (3), 548-563. e16, 2017 | 1683 | 2017 |
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity TJ Curiel, S Wei, H Dong, X Alvarez, P Cheng, P Mottram, R Krzysiek, ... Nature medicine 9 (5), 562-567, 2003 | 1567 | 2003 |
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy D Peng, I Kryczek, N Nagarsheth, L Zhao, S Wei, W Wang, Y Sun, E Zhao, ... Nature 527 (7577), 249-253, 2015 | 1121 | 2015 |
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments I Kryczek, M Banerjee, P Cheng, L Vatan, W Szeliga, S Wei, E Huang, ... Blood, The Journal of the American Society of Hematology 114 (6), 1141-1149, 2009 | 978 | 2009 |
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma I Kryczek, L Zou, P Rodriguez, G Zhu, S Wei, P Mottram, M Brumlik, ... The Journal of experimental medicine 203 (4), 871-881, 2006 | 933 | 2006 |
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells W Zou, V Machelon, A Coulomb-L'Hermin, J Borvak, F Nome, T Isaeva, ... Nature medicine 7 (12), 1339-1346, 2001 | 815 | 2001 |
Cancer nanomedicine for combination cancer immunotherapy J Nam, S Son, KS Park, W Zou, LD Shea, JJ Moon Nature Reviews Materials 4 (6), 398-414, 2019 | 775 | 2019 |
Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11 X Lang, MD Green, W Wang, J Yu, JE Choi, L Jiang, P Liao, J Zhou, ... Cancer discovery 9 (12), 1673-1685, 2019 | 748 | 2019 |
TH17 cells in tumour immunity and immunotherapy W Zou, NP Restifo Nature Reviews Immunology 10 (4), 248-256, 2010 | 743 | 2010 |
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. L Llorente, W Zou, Y Levy, Y Richaud-Patin, J Wijdenes, J Alcocer-Varela, ... The Journal of experimental medicine 181 (3), 839-844, 1995 | 694 | 1995 |
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment J Crespo, H Sun, TH Welling, Z Tian, W Zou Current opinion in immunology 25 (2), 214-221, 2013 | 682 | 2013 |